A whole genome sequencing assay named HPV-DeepSeek sniffs out signs of residual disease after surgery in patients with #HPV head and neck cancer, and detects recurrence earlier than digital PCR and standard clinical criteria. @FadenLab@BIDharvardOHNSscim.ag/3S52VLF
Big day for our lab! New paper using our HPV-DeepSeek assay, an ultrasensitive HPV WGS-based liquid biopsy for MRD detection in HPV head & neck cancer, is out today in @ScienceTM đź§µ
🔗 science.org/doi/10.1126/scit…
Huge thanks to our co-first authors Shun Hirayama, Yana Al-Inaya, @Michael_E_Bryan, @dipondas30 and @alanyelg. And to our clinical and scientific teams @MassEyeAndEar, @MassGeneralNews, Broad Institute, Broad Clincal Labs. This is what collaborative science looks like
Will be a great talk that bridges disciplines, from an outstanding post-doc! Can’t wait!
Thank you @HarvardCFAR for the funding support for this important work!
🧬 Two months until the inaugural Head and Neck Cancer Liquid Biopsy Summit! July 17, 2026 at @broadinstitute
We're bringing together the brightest minds in head and neck cancer liquid biopsy from academia and industry for an immersive day of science and collaboration
📅 July 17, 2026 | 8:30 AM–5:00 PM
📍Broad Institute, 415 Main Street, Cambridge, MA
âś… FREE registration for all (including trainees)
⚠️ 120 already registered—limited space remaining
Register and view the outstanding speaker lineup here: eventleaf.com/e/HeadandNeckC…
What a great series of meeting @AACR and @PacBio . Inspiring science with #liquidbiopsy reshaping all aspects of care. Congrats to our Qin Wang for great presentations. And so cool for our @CCR_AACR paper to be featured as top cancer early detection paper of the year!